Management challenges in metachronous bilateral breast cancer with discordant receptor status: a case report - Top-Institutions - MDSpire

Management challenges in metachronous bilateral breast cancer with discordant receptor status: a case report

  • By

  • Aime Ishimwe Mugisha

  • Gilbert Denis Umuhizi

  • Gerald Olwit

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #3

    Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine
    Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine

    Chicago, Illinois

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #4

    Weill Cornell Medical College
    Weill Cornell Medical College

    New York, New York

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #5

    University College Cork
    University College Cork

    Cork, Ireland

    Key Differentiators

    • Oncology
    • Breast Cancer

Original Source(s)

Management challenges in metachronous bilateral breast cancer with discordant receptor status: a case report

  • by Aime Ishimwe Mugisha, Gilbert Denis Umuhizi, Gerald Olwit

  • June 26, 2026

Related Content

Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis

A synergistic framework integrating global context and structural features for breast ultrasound lesion detection

Editorial: EBV strategies to counteract the immune response